BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26252227)

  • 1. PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer.
    Song Z; Liu W; Xiao Y; Zhang M; Luo Y; Yuan W; Xu Y; Yu G; Hu Y
    PLoS One; 2015; 10(8):e0128943. PubMed ID: 26252227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
    Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
    Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling.
    Qiao W; Wang H; Zhang X; Luo K
    Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline-Rich Protein 11 Regulates Self-Renewal and Tumorigenicity of Gastric Cancer Stem Cells.
    Hu H; Song Z; Yao Q; Geng X; Jiang L; Guo C; Li H
    Cell Physiol Biochem; 2018; 47(4):1721-1728. PubMed ID: 30007956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
    Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
    Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival.
    Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L
    Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRR11 Promotes Proliferation and Migration of Colorectal Cancer through Activating the EGFR/ERK/AKT Pathway via Increasing CTHRC1.
    Ma H; Yang W; Wang X; Dai G
    Ann Clin Lab Sci; 2022 Jan; 52(1):86-94. PubMed ID: 35181621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRR11 is a novel gene implicated in cell cycle progression and lung cancer.
    Ji Y; Xie M; Lan H; Zhang Y; Long Y; Weng H; Li D; Cai W; Zhu H; Niu Y; Yang Z; Zhang C; Song F; Bu Y
    Int J Biochem Cell Biol; 2013 Mar; 45(3):645-56. PubMed ID: 23246489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
    Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
    Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.
    Wang Y; Zhang C; Mai L; Niu Y; Wang Y; Bu Y
    BMB Rep; 2019 Feb; 52(2):157-162. PubMed ID: 30760381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.
    Zhang Z; She J; Yang J; Bu X; Ji G; Zhu S; He S; Chu D
    Mol Carcinog; 2018 Jun; 57(6):762-771. PubMed ID: 29500881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for potential gastric cancer markers using miRNA databases and gene expression analysis.
    Volkomorov V; Grigoryeva E; Krasnov G; Litviakov N; Tsyganov M; Karbyshev M; Zavyalova M; Afanasуev S; Cherdyntseva N; Lisitsyn N; Beresten S
    Exp Oncol; 2013 Mar; 35(1):2-7. PubMed ID: 23528308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
    Zhu J; Hu H; Wang J; Yang Y; Yi P
    Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma.
    Chen Y; Cha Z; Fang W; Qian B; Yu W; Li W; Yu G; Gao Y
    Oncotarget; 2015 Aug; 6(24):20419-33. PubMed ID: 25971332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
    Chen Y; Pang X; Ji L; Sun Y; Ji Y
    Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRR11 immunoreactivity is a weak prognostic factor in non-mucinous invasive adenocarcinoma of the lung.
    Sakai Y; Ohbayashi C; Yanagita E; Jimbo N; Kajimoto K; Sakuma T; Hirose T; Yoshimura M; Maniwa Y; Itoh T
    Pathologica; 2017 Sep; 109(3):133-139. PubMed ID: 29154370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
    Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
    Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.